Type |
Details |
Score |
Gene |
Type: |
gene |
Organism: |
macaque, rhesus |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
macaque, rhesus |
|
•
•
•
•
•
|
Publication |
First Author: |
Leng L |
Year: |
2003 |
Journal: |
J Exp Med |
Title: |
MIF signal transduction initiated by binding to CD74. |
Volume: |
197 |
Issue: |
11 |
Pages: |
1467-76 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nagarajan P |
Year: |
2014 |
Journal: |
Mol Cancer Res |
Title: |
MIF antagonist (CPSI-1306) protects against UVB-induced squamous cell carcinoma. |
Volume: |
12 |
Issue: |
9 |
Pages: |
1292-302 |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Publication |
First Author: |
Alfahel L |
Year: |
2024 |
Journal: |
Cell Rep Med |
Title: |
Targeting low levels of MIF expression as a potential therapeutic strategy for ALS. |
Volume: |
5 |
Issue: |
5 |
Pages: |
101546 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zheng Y |
Year: |
2015 |
Journal: |
Nat Cell Biol |
Title: |
Secreted and O-GlcNAcylated MIF binds to the human EGF receptor and inhibits its activation. |
Volume: |
17 |
Issue: |
10 |
Pages: |
1348-55 |
|
•
•
•
•
•
|
Publication |
First Author: |
Alaskarov A |
Year: |
2022 |
Journal: |
Sci Rep |
Title: |
MIF homolog d-dopachrome tautomerase (D-DT/MIF-2) does not inhibit accumulation and toxicity of misfolded SOD1. |
Volume: |
12 |
Issue: |
1 |
Pages: |
9570 |
|
•
•
•
•
•
|
Publication |
First Author: |
Suresh V |
Year: |
2022 |
Journal: |
FASEB J |
Title: |
MIF confers survival advantage to pancreatic CAFs by suppressing interferon pathway-induced p53-dependent apoptosis. |
Volume: |
36 |
Issue: |
8 |
Pages: |
e22449 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mun SH |
Year: |
2013 |
Journal: |
J Bone Miner Res |
Title: |
Deletion of CD74, a putative MIF receptor, in mice enhances osteoclastogenesis and decreases bone mass. |
Volume: |
28 |
Issue: |
4 |
Pages: |
948-59 |
|
•
•
•
•
•
|
Publication |
First Author: |
Schulz R |
Year: |
2014 |
Journal: |
Cell Death Dis |
Title: |
HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer. |
Volume: |
5 |
|
Pages: |
e980 |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Publication |
First Author: |
Korf H |
Year: |
2017 |
Journal: |
PLoS One |
Title: |
MIF inhibition interferes with the inflammatory and T cell-stimulatory capacity of NOD macrophages and delays autoimmune diabetes onset. |
Volume: |
12 |
Issue: |
11 |
Pages: |
e0187455 |
|
•
•
•
•
•
|
Allele |
Name: |
SMT3 suppressor of mif two 3 homolog 2, pseudogene 2 (S. cerevisiae); wild type |
Allele Type: |
Not Specified |
|
|
•
•
•
•
•
|
Allele |
Name: |
SMT3 suppressor of mif two 3 homolog 2, pseudogene (S. cerevisiae); wild type |
Allele Type: |
Not Specified |
|
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
115
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Leyton-Jaimes MF |
Year: |
2019 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS. |
Volume: |
116 |
Issue: |
29 |
Pages: |
14755-14760 |
|
•
•
•
•
•
|
GO Term |
|
•
•
•
•
•
|
Publication |
First Author: |
Nishioka Y |
Year: |
1989 |
Journal: |
Cytogenet Cell Genet |
Title: |
Genome comparison in the genus Mus: a study with B1, MIF (mouse interspersed fragment), centromeric, and Y-chromosomal repetitive sequences. |
Volume: |
50 |
Issue: |
4 |
Pages: |
195-200 |
|
•
•
•
•
•
|
Allele |
Name: |
macrophage migration inhibitory factor (glycosylation-inhibiting factor); endonuclease-mediated mutation 1, Shanghai Model Organisms Center |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Allele |
Name: |
macrophage migration inhibitory factor (glycosylation-inhibiting factor); endonuclease-mediated mutation 3, Shanghai Model Organisms Center |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
Publication |
First Author: |
Seidel F |
Year: |
2022 |
Journal: |
Int J Mol Sci |
Title: |
Therapeutic Intervention with Anti-Complement Component 5 Antibody Does Not Reduce NASH but Does Attenuate Atherosclerosis and MIF Concentrations in Ldlr-/-.Leiden Mice. |
Volume: |
23 |
Issue: |
18 |
|
|
•
•
•
•
•
|
GO Term |
|
•
•
•
•
•
|
GO Term |
|
•
•
•
•
•
|
GO Term |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, mutant strain, endonuclease-mediated mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, mutant strain, endonuclease-mediated mutation |
|
•
•
•
•
•
|
HT Experiment |
|
Experiment Type: |
transcription profiling by array |
Study Type: |
WT vs. Mutant |
Source: |
ArrayExpress |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
Mus caroli |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Pseudogene |
Type: |
pseudogene |
Organism: |
Mus spretus |
|
•
•
•
•
•
|
Publication |
First Author: |
Brunkow ME |
Year: |
2001 |
Journal: |
Nat Genet |
Title: |
Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. |
Volume: |
27 |
Issue: |
1 |
Pages: |
68-73 |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 279, Douglas Arenberg |
Allele Type: |
Transgenic |
Attribute String: |
Inducible, Inserted expressed sequence |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, transgenic |
|
•
•
•
•
•
|
HT Experiment |
|
Experiment Type: |
RNA-Seq |
Study Type: |
WT vs. Mutant |
Source: |
ArrayExpress |
|
•
•
•
•
•
|
Publication |
First Author: |
Sugimoto H |
Year: |
1999 |
Journal: |
Biochemistry |
Title: |
Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution. |
Volume: |
38 |
Issue: |
11 |
Pages: |
3268-79 |
|
•
•
•
•
•
|
Publication |
First Author: |
Van Molle W |
Year: |
2005 |
Journal: |
Eur J Immunol |
Title: |
How glucocorticoids control their own strength and the balance between pro- and anti-inflammatory mediators. |
Volume: |
35 |
Issue: |
12 |
Pages: |
3396-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Matsunaga J |
Year: |
1999 |
Journal: |
Cell Mol Biol (Noisy-le-grand) |
Title: |
Macrophage migration inhibitory factor (MIF)--its role in catecholamine metabolism. |
Volume: |
45 |
Issue: |
7 |
Pages: |
1035-40 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Conserved_site |
Description: |
Macrophage migration inhibitory factor (MIF) is a key regulatory cytokine within innate and adaptive immune responses, capable of promoting and modulating the magnitude of the response []. MIF is released from T-cells and macrophages, and acts within the neuroendocrine system. MIF is capable of tautomerase activity, although its biological function has not been fully characterised. It is induced by glucocorticoid and is capable of overriding the anti-inflammatory actions of glucocorticoid []. MIF regulates cytokine secretion and the expression of receptors involved in the immune response. It can be taken up into target cells in order to interact with intracellular signalling molecules, inhibiting p53 function, and/or activating components of the mitogen-activated protein kinase and Jun-activation domain-binding protein-1 (Jab-1) []. MIF has been linked to various inflammatory diseases, such as rheumatoid arthritis and atherosclerosis [].The MIF homologue D-dopachrome tautomerase () is involved in detoxification through the conversion of dopaminechrome (and possibly norepinephrinechrome), the toxic quinine product of the neurotransmitter dopamine (and norepinephrine), to an indole derivative that can serve as a precursor to neuromelanin [, ].The signature pattern for this entry is formed from a conserved region located in the central section. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Macrophage migration inhibitory factor (MIF) is a key regulatory cytokine within innate and adaptive immune responses, capable of promoting and modulating the magnitude of the response []. MIF is released from T-cells and macrophages, and acts within the neuroendocrine system. MIF is capable of tautomerase activity, although its biological function has not been fully characterised. It is induced by glucocorticoid and is capable of overriding the anti-inflammatory actions of glucocorticoid []. MIF regulates cytokine secretion and the expression of receptors involved in the immune response. It can be taken up into target cells in order to interact with intracellular signalling molecules, inhibiting p53 function, and/or activating components of the mitogen-activated protein kinase and Jun-activation domain-binding protein-1 (Jab-1) []. MIF has been linked to various inflammatory diseases, such as rheumatoid arthritis and atherosclerosis [].The MIF homologue D-dopachrome tautomerase () is involved in detoxification through the conversion of dopaminechrome (and possibly norepinephrinechrome), the toxic quinine product of the neurotransmitter dopamine (and norepinephrine), to an indole derivative that can serve as a precursor to neuromelanin [, ]. |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Publication |
First Author: |
Means GD |
Year: |
2000 |
Journal: |
Genomics |
Title: |
A transcript map of a 2-Mb BAC contig in the proximal portion of the mouse X chromosome and regional mapping of the scurfy mutation. |
Volume: |
65 |
Issue: |
3 |
Pages: |
213-23 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
118
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
115
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
73
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
118
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Donn RP |
Year: |
2004 |
Journal: |
J Endocrinol |
Title: |
Macrophage migration inhibitory factor: molecular, cellular and genetic aspects of a key neuroendocrine molecule. |
Volume: |
182 |
Issue: |
1 |
Pages: |
1-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Morand EF |
Year: |
2006 |
Journal: |
Nat Rev Drug Discov |
Title: |
MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. |
Volume: |
5 |
Issue: |
5 |
Pages: |
399-410 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gimm T |
Year: |
2010 |
Journal: |
FASEB J |
Title: |
Hypoxia-inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia-inducible factor-1. |
Volume: |
24 |
Issue: |
11 |
Pages: |
4443-58 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
64
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Togashi A |
Year: |
2005 |
Journal: |
Cancer Res |
Title: |
Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for renal cell carcinoma and potential target for molecular therapy. |
Volume: |
65 |
Issue: |
11 |
Pages: |
4817-26 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nishimura S |
Year: |
2011 |
Journal: |
Eur J Gynaecol Oncol |
Title: |
Expression of hypoxia-inducible 2 (HIG2) protein in uterine cancer. |
Volume: |
32 |
Issue: |
2 |
Pages: |
146-9 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Hypoxia-inducible lipid droplet-associated protein (HILPDA), also known as hypoxia-inducible protein 2 (HIG2), increases intracellular lipid accumulation. It stimulates expression of cytokines including IL6, MIF and VEGFA. It also enhances cell growth and proliferation [, ]. Human HILPDA is highly expressed in renal cell carcinoma cells but barely detectable in adjacent normal kidney tissue. It is detected in some cervical and endometrial cancers [, , ]. |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen A |
Year: |
1998 |
Journal: |
Biochem Mol Biol Int |
Title: |
Characterization of mouse ubiquitin-like SMT3A and SMT3B cDNAs and gene/pseudogenes. |
Volume: |
46 |
Issue: |
6 |
Pages: |
1161-74 |
|
•
•
•
•
•
|